AMANDA THOMPSON: Open Payments
NPI 1144690413 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$21,971 in 158 payments from 30 companies in 2025. Trend: 2023 $7,843 · 2024 $11,785 · 2025 $21,971
Speaker / faculty: $18,838Food & beverage: $2,697Travel & lodging: $324Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 59 | $19,748 |
| Alexion Pharmaceuticals, Inc. | 6 | $321 |
| Teva Pharmaceuticals USA, Inc. | 9 | $240 |
| Inspire Medical Systems, Inc. | 7 | $141 |
| Lilly USA, LLC | 11 | $140 |
| Genentech USA, Inc. | 5 | $120 |
| TG Therapeutics, Inc. | 5 | $119 |
| Biogen, Inc. | 5 | $108 |
| EMD Serono, Inc. | 3 | $103 |
| SK Life Science, Inc. | 4 | $103 |
Products named: QULIPTA, UBRELVY, ULTOMIRIS, INSPIRE, AUSTEDO XR, BRIUMVI, Ocrevus Zunovo, ZEPOSIA.
Industry payments across ID — which companies pay providers there.
